Literature DB >> 2551640

The human liver growth hormone receptor.

J F Hocquette1, M C Postel-Vinay, C Kayser, B de Hemptinne, A Amar-Costesec.   

Abstract

Human livers, obtained from donors at the time of transplant, were homogenized in 0.25 M sucrose and fractionated by differential centrifugation. The specific binding of [125I] human (h) GH to total particulate fractions from 18 livers varied from 0.4-5.1% of the total radioactivity/100 micrograms protein. Binding affinity was 2.0 +/- 0.3 X 10(9) M-1, and binding capacity ranged from 14-53 fmol/mg protein. A different proportion of receptors occupied by endogenous hGH did not explain the large variation in binding. Binding sites were specific for hGH. Dissociation of the hormone-receptor complex was extremely slow. No specific binding of [125I]hPRL was observed. Specific binding of insulin was found in fractions from all livers and varied less than hGH binding. Cross-linking of [125I]hGH to plasma membrane and microsome receptors yielded two major autoradiographic bands corresponding to an estimated mol wt of 103,000 for the receptor, with a possible subunit of 54,000. Human liver primary fractions were characterized. The binding of hGH and insulin displayed a nucleo-microsomal distribution pattern in the primary fractions; 54.2% and 27.9% of the hGH-binding activity were found in the microsomes and the nuclear fraction, respectively, whereas insulin binds equally to nuclear and microsomal elements. Our findings suggest that hGH-binding sites are present in the plasma membrane and also in one or more intracellular compartments, whereas a high proportion of insulin receptors is associated with the plasma membrane.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2551640     DOI: 10.1210/endo-125-4-2167

Source DB:  PubMed          Journal:  Endocrinology        ISSN: 0013-7227            Impact factor:   4.736


  6 in total

1.  Immunocytochemical demonstration of the binding and internalization of growth hormone in GERL of Chang hepatoma cells.

Authors:  J J Wang; J P Chang; C S Teng
Journal:  Cell Tissue Res       Date:  1990-11       Impact factor: 5.249

2.  Allosteric effects of monoclonal antibodies on human growth hormone.

Authors:  R C Aguilar; L A Retegui; M C Postel-Vinay; L P Roguin
Journal:  Mol Cell Biochem       Date:  1994-07-13       Impact factor: 3.396

3.  Expression of growth hormone receptor and its mRNA in hepatic cirrhosis.

Authors:  Hong-Tao Wang; Shuang Chen; Jie Wang; Qing-Jia Ou; Chao Liu; Shu-Sen Zheng; Mei-Hai Deng; Xiao-Ping Liu
Journal:  World J Gastroenterol       Date:  2003-04       Impact factor: 5.742

4.  Defective membrane expression of human growth hormone (GH) receptor causes Laron-type GH insensitivity syndrome.

Authors:  P Duquesnoy; M L Sobrier; S Amselem; M Goossens
Journal:  Proc Natl Acad Sci U S A       Date:  1991-11-15       Impact factor: 11.205

5.  Protective effects of recombinant human growth hormone on cirrhotic rats.

Authors:  Shuang Chen; Hong-Tao Wang; Bin Yang; Yu-Ru Fu; Qing-Jia Ou
Journal:  World J Gastroenterol       Date:  2004-10-01       Impact factor: 5.742

6.  Lack of hormone binding in COS-7 cells expressing a mutated growth hormone receptor found in Laron dwarfism.

Authors:  M Edery; M Rozakis-Adcock; L Goujon; J Finidori; C Lévi-Meyrueis; J Paly; J Djiane; M C Postel-Vinay; P A Kelly
Journal:  J Clin Invest       Date:  1993-03       Impact factor: 14.808

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.